Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
10.503
Zitationen
13
Autoren
2005
Jahr
Abstract
Nonalcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis in the absence of a history of significant alcohol use or other known liver disease. Nonalcoholic steatohepatitis (NASH) is the progressive form of NAFLD. The Pathology Committee of the NASH Clinical Research Network designed and validated a histological feature scoring system that addresses the full spectrum of lesions of NAFLD and proposed a NAFLD activity score (NAS) for use in clinical trials. The scoring system comprised 14 histological features, 4 of which were evaluated semi-quantitatively: steatosis (0-3), lobular inflammation (0-2), hepatocellular ballooning (0-2), and fibrosis (0-4). Another nine features were recorded as present or absent. An anonymized study set of 50 cases (32 from adult hepatology services, 18 from pediatric hepatology services) was assembled, coded, and circulated. For the validation study, agreement on scoring and a diagnostic categorization ("NASH," "borderline," or "not NASH") were evaluated by using weighted kappa statistics. Inter-rater agreement on adult cases was: 0.84 for fibrosis, 0.79 for steatosis, 0.56 for injury, and 0.45 for lobular inflammation. Agreement on diagnostic category was 0.61. Using multiple logistic regression, five features were independently associated with the diagnosis of NASH in adult biopsies: steatosis (P = .009), hepatocellular ballooning (P = .0001), lobular inflammation (P = .0001), fibrosis (P = .0001), and the absence of lipogranulomas (P = .001). The proposed NAS is the unweighted sum of steatosis, lobular inflammation, and hepatocellular ballooning scores. In conclusion, we present a strong scoring system and NAS for NAFLD and NASH with reasonable inter-rater reproducibility that should be useful for studies of both adults and children with any degree of NAFLD. NAS of > or =5 correlated with a diagnosis of NASH, and biopsies with scores of less than 3 were diagnosed as "not NASH."
Ähnliche Arbeiten
Global Prevalence of Diabetes
2004 · 15.266 Zit.
Phosphorus Assay in Column Chromatography
1959 · 12.850 Zit.
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 · 11.301 Zit.
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
2015 · 10.529 Zit.
Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator
2016 · 9.316 Zit.
Autoren
Institutionen
- National Institutes of Health(US)
- National Cancer Institute(US)
- Saint Louis University(US)
- University of California, San Diego(US)
- Virginia Commonwealth University(US)
- Indiana University Hospital(US)
- University of California, San Francisco(US)
- MetroHealth(US)
- MetroHealth Medical Center(US)
- Johns Hopkins Hospital(US)
- University of Washington Medical Center(US)
- Virginia Commonwealth University Medical Center(US)